Find out what Breast Cancer Care is saying about the latest drug treatments, research papers and health policy issues.

If you’re a journalist working on a story and need an expert quote, call us on 0345 092 0807 (out of hours 07702 901 334).

Responding to the decision by the Department of Health and Social Care to give the Cancer Patient Experience Survey permanent exemption from the...

16 January 2019

Discussing the news that the Scottish Medical Consortium (SMC) has approved pertuzumab (Perjeta) for use on NHS Scotland to treat secondary...

14 January 2019

Responding to the publication of the NHS Long Term Plan, Samia al Qadhi, Chief Executive of Breast Cancer Care, says: “This long-overdue...

7 January 2019

Discussing the results of testing Tinagl1, an experimental new protein treatment, on mice with triple negative breast cancer, Grete Brauten-Smith,...

4 January 2019

Responding to NHS Digital data revealing that uptake of routine breast screening invitations amongst women aged 50-70 has fallen to 70.5% Addie...

20 December 2018

Responding to NICE final guidance that three tumour profiling tests will be available to guide adjuvant chemotherapy decisions in people with early...

19 December 2018

Responding to the publication of the Independent Breast Screening Review report, announced in May following a serious incident in the screening...

13 December 2018

Responding to news that the Scottish Medical Consortium (SMC) has approved the use of pertuzumab (Perjeta) for neo-adjuvant treatment of HER2-...

10 December 2018

Responding to a parliamentary question answered by Scottish Government, which reveals that there is a backlog in breast screening in some areas of...

5 December 2018